Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19

NCT04456361 is registered in ClinicalTrials.gov with Instituto de Medicina Regenerativa as lead sponsor.

NCT NCT04456361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04456361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19
Lead sponsor
Instituto de Medicina Regenerativa
Phase
Phase 1
Overall status
Unknown status
Start date
April 16, 2020
Completion date
November 15, 2025
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, covid-19